confide
发表于 2025-3-30 12:07:34
http://reply.papertrans.cn/79/7809/780822/780822_51.png
Corral
发表于 2025-3-30 14:32:00
Other Metrics That Have Been Proposed to Optimize Drug Development Decisions,into their decision process. In this chapter, we review two approaches that have been proposed to quantitatively incorporate cost into design considerations. The first one optimizes a benefit–cost efficiency score that measures the cost-effectiveness of a proof-of-concept trial design. The second ap
Heart-Rate
发表于 2025-3-30 20:06:12
http://reply.papertrans.cn/79/7809/780822/780822_53.png
Neutropenia
发表于 2025-3-30 23:39:41
http://reply.papertrans.cn/79/7809/780822/780822_54.png
离开就切除
发表于 2025-3-31 04:54:35
Additional Topics,ssessment of program-level success probability when a program includes multiple studies in different phases of a disease, joint analysis of efficacy and safety endpoints, using prior information at the pre-clinical stage, and sources for data and information. We caution about changes in statistical
赔偿
发表于 2025-3-31 05:46:01
http://reply.papertrans.cn/79/7809/780822/780822_56.png